Citadel Advisors’s NLS Pharmaceutics NLSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,407
| Closed | -$29.6K | – | 6391 |
|
|
2024
Q2 | $29.6K | Buy |
3,407
+2,927
| +610% | +$25.4K | ﹤0.01% | 5321 |
|
|
2024
Q1 | $3.49K | Buy |
+480
| New | +$3.49K | ﹤0.01% | 5808 |
|
|
2022
Q2 | – | Sell |
-541
| Closed | -$31K | – | 6620 |
|
|
2022
Q1 | $31K | Buy |
+541
| New | +$31K | ﹤0.01% | 6050 |
|
|
2021
Q4 | – | Sell |
-511
| Closed | -$51K | – | 6926 |
|
|
2021
Q3 | $51K | Buy |
511
+247
| +94% | +$24.7K | ﹤0.01% | 6110 |
|
|
2021
Q2 | $33K | Buy |
+264
| New | +$33K | ﹤0.01% | 6278 |
|